Mechanistic Investigation of the Time-Dependent Aldehyde Oxidase Inhibitor Hydralazine.
Journal
Drug metabolism and disposition: the biological fate of chemicals
ISSN: 1521-009X
Titre abrégé: Drug Metab Dispos
Pays: United States
ID NLM: 9421550
Informations de publication
Date de publication:
06 2023
06 2023
Historique:
received:
11
01
2023
accepted:
10
03
2023
medline:
15
5
2023
pubmed:
16
3
2023
entrez:
15
3
2023
Statut:
ppublish
Résumé
The anti-hypertensive agent hydralazine is a time-dependent inhibitor of the cytosolic drug-metabolizing enzyme aldehyde oxidase (AO). Glutathione (GSH) was found to suppress the inhibition of AO by hydralazine in multiple enzyme sources (human liver and kidney cytosol, human liver S9, rat liver S9, and recombinant human AO) and with different AO substrates (zoniporide,
Identifiants
pubmed: 36921993
pii: dmd.123.001257
doi: 10.1124/dmd.123.001257
doi:
Substances chimiques
Aldehyde Oxidase
EC 1.2.3.1
Catalase
EC 1.11.1.6
Dantrolene
F64QU97QCR
Hydralazine
26NAK24LS8
Phthalazines
0
Glutathione
GAN16C9B8O
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
782-791Informations de copyright
Copyright © 2023 by The American Society for Pharmacology and Experimental Therapeutics.